Our CEO Leo Ehrlich has the MENTAL Toughness to deal with

New Post Public Reply Private Reply Replies (0) Message Board
biomanbaba petemantx #5377

Our CEO Leo Ehrlich has the MENTAL Toughness to deal with the MANIPULATORS...lets do our part and help him out


Dear Fellow Shareholders’ of Cellceutix, 

It appears that this past Thursday and Friday ( December 27 and 28), there was a “short attack” against the Company. Now, to short a company’s stock is not illegal. However MARKET MANIPULATION IS HIGHLY ILLEGAL. 

Shares of CTIX closed Wednesday at $2.42. It has been noted by many shareholders that in pre-market activity on Thursday morning there appeared several trades of CTIX at $0.80 and even lower, each of which were canceled shortly before the open. Simply, we believe that is called “PAINTING THE TAPE”, a type of illegal market manipulation and something that our Company will unequivocally not ignore. 

The opinion of Cellceutix is that these actions were a coordinated effort amongst a group that planned to drive down the price of Cellceutix stock for their own benefit by creating illusions that stockholders are panicking or that Cellceutix’s accomplishments are without merit. For example, several articles and “bashers” surfaced writing negative commentary on Cellceutix that were published on different, popular financial websites. 

Then as they short the stock, which causes the share price to decline, the small investor thinks other investors are selling and they join this perceived stampede. It is a smoke screen they have created. If you look at Friday’s sales in the approximate $1.55 range, you see the number of small trades by the small shareholder panicking. Exactly what they want to create. 

Now that we know the situation that we are dealing with, what can one do? 

The answer is an examination of the premarket trades of Thursday, December 27, 2012 by the regulatory authorities. If audits of those transactions provide evidence that they were illegal, the government has the tools at its discretion to trace all cell phone records, emails, financial transactions, etc. made by these individuals acting for themselves or others. In this day and age nothing is hidden. If this leads to evidence that market makers, writers, bashers and others have conspired in this illegal act, they should be held accountable and suffer the consequences. 

Even if market makers and writers were acting on behalf of clients overseas, they will be held accountable. Claiming they didn’t know is not an excuse. We saw what happened with the Madoff scandal and how feeder funds were held responsible. During the past two days, the CTIX price per share declined by $0.69. The market capitalization of the company declined over $60 million. If someone were to rob a bank of $60 million, you can be certain the authorities would be on top of it. 

Again, shorting is legal, but MARKET MANIPULATION is illegal. 

The parties that we believe are behind this seem to be a very sophisticated group. Therefore, to help the authorities you must expose the weakest link in their strategy: the pre-market manipulation of Thursday morning that they tried later to cover up and hide. This is also a warning to their associates that they may be aiding a group that has engaged in market manipulation and this activity may have repercussions to them as well. 

I have spoken to the Financial Industry Regulatory Authority (FINRA) and have made a complaint as to the pre-market activity of Thursday morning. I am only one person. If the hundreds, or even thousands, of CTIX shareholders and supporters also file a complaint about the need to investigate the Thursday morning pre-market activity I believe this will be taken very seriously by the authorities, and cause many sleepless nights for those who are involved in this ILLEGAL MARKET MANIPULATION. 

Interested parties are encouraged to call or email the office of the whistleblower at FINRA about the “THURSDAY MORNING PRE-MARKET ACTIVITY” and any other irregularity that has been observed. You should also inform them of any articles you notice bashing the company or new bashers that appear on message boards as these may be tied in to the individuals who were responsible for the market manipulation. 

http://www.finra.org/Industry/Whistleblower/


Office of the Whistleblower 
Dedicated Team to Handle High-Risk Tips 

FINRA's Office of the Whistleblower expedites the review of high-risk tips by FINRA senior staff and ensures a rapid response for tips believed to have merit. 

Through the Office of the Whistleblower, individuals with evidence of, or material information about, potentially illegal or unethical activity can reach senior staff, who can quickly assess the level of risk involved and make sure that each tip is properly evaluated. Those tips warranting additional review and investigation will be subject to an expedited regulatory response. 

FINRA will refer any whistleblower tips that fall outside its jurisdictional reach to the appropriate regulatory or law enforcement agencies. 

FINRA's whistleblower initiative does not replace longstanding processes for handling thousands of routine regulatory tips and customer complaints each year. 

Submit a Tip 
whistleblower@finra.org 
1-866-96-FINRA (1-866-963-4672) 



Thank you for your continued support, 

Leo Ehrlich 
Chief Executive Officer, Cellceutix Corporation 

Copyright © 2012 Cellceutix Corporation, All rights reserved. 
You requested to receive email alerts about Cellceutix at our website www.cellceutix.com 
Our mailing address is: 
Cellceutix Corporation 
100 Cumming Center, Suite 151-B 
Beverly, MA 01915 
ALWAYS TAKE YOUR BASIS OFF THE TABLE..........IF YOU OBEY THIS RULE YOU CAN NEVER LOSE YOUR ASS 
The Magnificent Seven are CTIX CLSN THLD SNTA SBFM PCYC IMUC
ALWAYS TAKE YOUR BASIS OFF THE TABLE..........IF YOU OBEY THIS RULE YOU CAN NEVER LOSE YOUR ASS 
The Magnificent Seven are CTIX CLSN THLD SNTA SBFM PCYC IMUC

Innovation Pharmaceuticals Inc (IPIX) Stock Research Links

IPIX Board Company Profile Buy Rating Time & Sales News Filings Financials
Scroll down for more posts ▼

Top 10 Most Recent News Articles

What to Expect: Your First Therapy Session Insights

Updated Category News Views 169

Starting With the Unknown: The Therapy Journey Begins Rolling into that first therapy session can feel like walking into a mystery with no clues. You're not alone if it stirs up some nerves—most folks feel the same, especially when it's your first rodeo in mental health support. That's where Cody Luke and David Spencer of Luke and Spencer Behavioral Health, based out in...

Continue Reading
Bio-Thera's New Data: A Game Changer for NSCLC?

Updated Category News Views 337

A Fresh Look at Lung Cancer Solutions There's fresh meat on the oncology block, with Bio-Thera Solutions swinging for the fences at ESMO 2026, spotlighting promising Phase 2 clinical data for their combo treatment in first-line non-small cell lung cancer (NSCLC). If you're tuned into the biopharmaceutical sector or just keeping tabs on global health romps, this news sets...

Continue Reading
TORRAS Stands Tall with iPhone 18 Pro Cases

Updated Category News Views 191

TORRAS Shines in Magnetic Stand Case Evaluation In the whirlwind of smartphone accessories, where the battle lines are drawn between protection and functionality, TORRAS has emerged victorious with its magnetic stand cases for the iPhone 18 Pro and its beefier brother, the iPhone 18 Pro Max. Expert Consumers—a trusted name in product evaluations—has given TORRAS the...

Continue Reading
CapCut's AI Tools Reshape Video Content Creation

Updated Category News Views 143

AI Revolution in Marketing Content: CapCut Takes Lead It's like the old guard of marketing has hitched a ride on a rocket. In 2026, CapCut has stomped into the limelight with Better Business Advice giving them a nod for their prowess in AI-driven content creation. This isn't some passing trend; it's a seismic shift in how businesses craft their messages. CapCut ain't just...

Continue Reading
World Young Scientist Summit 2026 in Wenzhou Kicks Off

Updated Category News Views 154

Young Minds Meet AI Innovation Crack open the playbook, and it's clear: young brains from across the globe are gathering in Wenzhou, Zhejiang, China, to wrangle with AI and chart the course of science toward a sustainable future. The World Young Scientist Summit 2026 isn't just a parade of speeches and accolades. Nah, it's a deep dive into where innovative minds believe...

Continue Reading
Amgen's IMDELLTRA® Shows Promise in SCLC Battle

Updated Category News Views 352

Breakthrough Results in SCLC Treatment For years, small cell lung cancer (SCLC) has been the unruly beast in the oncology world, defying treatment advances and keeping survival rates stubbornly low. This nasty foe might just have met its match, folks. Amgen (NASDAQ:AMGN) announced results from their Phase 3 DeLLphi-305 trial that show their drug IMDELLTRA®, when teamed...

Continue Reading
Likang's Bold Move: Cancer Immunotherapy at AD Summit

Updated Category News Views 134

Cancer Care Takes Center Stage Kicking off with a bang in Abu Dhabi, Likang Life Sciences has made a splash in the world of personalized cancer immunotherapy. The Abu Dhabi Future Health Summit 2026 served as the backdrop for this bold move, lighting up discussions with their AI-enabled innovations. Likang's showing at the Summit wasn't just another walk in the park—it...

Continue Reading
Innovent's IBI354: New Data Spurs Hope for HER2+ BC

Updated Category News Views 0

Innovent Lauds HER2 ADC's Moment at ESMO 2026 Alright, chin up, investors. At the 2026 ESMO Congress, Innovent's throwing down some promising Phase 2 data for their brainchild, IBI354. You hear that name and it's like hearing about a rock star in the making in the oncology world. The potential here isn’t just talk—it's a loud, resounding call for attention. Their...

Continue Reading
ST Engineering iDirect, MBSat Forge Middle East Satellite Hub

Updated Category News Views 37

Satellite Services Take Off in the Middle East Never thought the day would come where the Middle East is on the threshold of leapfrogging satellite tech, but here we are. ST Engineering iDirect just locked arms with MBSat—yep, that's part of the Mohammed Al Barwani Group—to birth a next-gen satellite connectivity service hub in Oman and across surrounding areas....

Continue Reading
Wenda Pharma's NHWD-870 HCl Shows Promise in Trial

Updated Category News Views 163

Breaking Through in NUT Carcinoma Treatment Imagine battling an aggressive disease with barely any options left, and then something hopeful shows up in the pipeline. That's the story with Zhejiang Wenda Pharma's NHWD-870 HCl, an oral BET inhibitor making waves at the 2026 ESMO Annual Meeting. Facing off against the nasty beast that is NUT carcinoma, this drug didn't just...

Continue Reading

Top 5 Most Recently Viewed Articles

BerGenBio Welcomes First Patient in Lung Cancer Study

Updated Category News Views 202

BerGenBio Embarks on Promising Lung Cancer Trial BerGenBio ASA, a clinical-stage biopharmaceutical company dedicated to combating serious diseases through innovative therapies, has reached a significant milestone in its journey. The company has successfully included the first patient in its clinical trial, focusing on the cutting-edge AXL kinase inhibitor known as...

Continue Reading
CIMG Inc. Introduces Tokenized Stock on FlowStocks Platform

Updated Category News Views 247

CIMG Inc. Introduces Tokenized Stock on FlowStocks Platform CIMG Inc. (NASDAQ: IMG), a dynamic group in the digital health and sales development sector, has officially launched its tokenized stock on the FlowStocks platform. This exciting development follows successful testing and represents a significant shift in how the company interacts with its investors. The new...

Continue Reading
Exploring the Impact of New SEC Leadership on Cryptocurrency

Updated Category News Views 179

New Era for Cryptocurrency Under SEC Leadership The recent changes at the Securities and Exchange Commission (SEC) under new leadership signal a transformative period for the cryptocurrency market. These developments could reshape the regulatory landscape, offering clarity and direction for investors and companies involved in the digital asset space. Understanding the...

Continue Reading
Shytoshi Kusama Transitions Roles: Shiba Inu's New Direction

Updated Category News Views 190

Shytoshi Kusama Transitions to New Leadership Role Shytoshi Kusama, the driving force behind the Shiba Inu ecosystem, has made a significant change by stepping down from his role as the lead visionary. This pivotal shift marks a transition to the position of lead ambassador, as he aims to spearhead global adoption more effectively. The Shift in Leadership Announcing his...

Continue Reading
BASF Shares Fall Following Proposed Dividend Cuts to Shareholders

Updated Category News Views 281

BASF (ETR:BASFN) just took a hit on its stock price after announcing some major shifts in its dividend policy. Shares plummeted by 2.9% to €44.035, all thanks to the company's new proposed minimum annual dividend of €2.25 per share for the upcoming 2024 business year. That’s a stark drop from the previous €3.40 per share they dished out in 2023—talk about making...

Continue Reading